Longitudinal Population-based Observational Study of COVID-19 in the UK Population
ConditionCOVID-19
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorQueen Mary University of London
About this trial
COVIDENCE UK is a population-based observational longitudinal study that has the following objectives:
1. To determine risk factors for incident COVID-19 and for adverse outcomes of COVID-19 in the UK population 2. To characterise the natural history of COVID-19 in the UK population 3. To evaluate the impact of COVID-19 on the physical and mental health of the UK population 4. To provide a resource from which to identify potential participants for future clinical trials, and to use data collected in COVIDENCE as comparison or control data for trial participants who have been randomised to receive one or more interventions.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
UK resident
Age ≥16 years
Disqualifiers
None
Trial population
UK residents aged 16 years or more
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Incidence of confirmed COVID-19
Time frame
5 yearsSecondary outcomes
1
Incidence of probable or suspected COVID-19
Time frame
5 years2
Incidence of COVID-19 requiring hospitalisation
Time frame
5 years3
Incidence of COVID-19 requiring ventilatory support
Time frame
5 years4
Incidence of fatal COVID-19
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Queen Mary University of London
Lead sponsor
King's College London
Collaborator
London School of Hygiene and Tropical Medicine
Collaborator
University of Edinburgh
Collaborator
Swansea University
Collaborator
Queen's University, Belfast
Collaborator
Barts & The London NHS Trust
Collaborator
Source ClinicalTrials.gov